InvestorsHub Logo
Followers 0
Posts 4
Boards Moderated 0
Alias Born 04/03/2023

Re: None

Monday, 04/03/2023 12:48:17 AM

Monday, April 03, 2023 12:48:17 AM

Post# of 257
Temperate your expectations in R/R PTCL : ORR 30% mDoR >6 months are the bar to achieve.

I am crvs shareholder to and follow the company and 818 dvpt since several years.
The early data generated so far are excellent and much more strong than current soc in R/R ptcl.
The goal to achieve for the 7 new patients is not to maintain current data but to demonstrate patients interest and competitive value. Physicians expectations in this setting is to have a safe drug with ORR > 25-30% and duration response > 6 months.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRVS News